---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-114919"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:42:00.247460+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dogwood Therapeutics completes business combination with Sealbond; approves equity plan adding 2.78M shares

## Summary
- Stockholders approved the potential issuance of common stock upon conversion of Series A, A-1, and A-2 preferred stock.
- Business combination with Sealbond Limited (per Share Exchange Agreement dated Oct 7, 2024) is now complete.
- Second Amended and Restated Equity Incentive Plan approved, increasing reserved shares from 191,122 to 2,972,787.
- Special meeting quorum: 820,239 shares (35.76% of voting power) as of Oct 14, 2025 record date.
- All five proposals passed with >772K votes for, including adjournment and plan approval.

## SEC filing metadata
- accession: 0001104659-25-114919
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/0001104659-25-114919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/dwtx-20251121x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-114919
- JSON: https://secwatch.observer/filing/0001104659-25-114919.json
- Plain text: https://secwatch.observer/filing/0001104659-25-114919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.